NCT05252156View on ClinicalTrials.gov

eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

March 21, 2022

Primary Completion Date

October 26, 2022

Study Completion Date

October 31, 2022

Conditions
Sleep Apnea, Obstructive
Interventions
DEVICE

eXciteOSA

eXciteOSA

Trial Locations (7)

21286

Pulmonary and Critical Care Associates of Baltimore, Baltimore

29201

Bogan Sleep Consultants, Columbia

33971

Florida Lung & Sleep Associates, Lehigh Acres

35213

Sleep Disorders Center of Alabama, Birmingham

43017

Ohio Sleep Medicine Institute, Dublin

63143

Clayton Sleep Institute, St Louis

80918

Delta Waves, Colorado Springs

Sponsors
All Listed Sponsors
lead

Signifier Medical Technologies

INDUSTRY

NCT05252156 - eXciteOSA for Treatment of Moderate Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter